Virus News and Research

Latest Virus News and Research

Chica and Heinz Schaller Foundation supports work of five new C.H.S. research groups

Five new research groups for young scientists, the C.H.S. research groups, have taken up their work in basic biomedical research. To mark the occasion, the German Cancer Research Center (DKFZ) will hold a ceremony on 20 July 2012.

14 Jul 2012

Studies show success, highlight challenges of PrEP strategy

The results of three clinical trials published on Wednesday in the New England Journal of Medicine show that the antiretroviral drug Truvada, a combination of tenofovir and emtracitabine, can be "highly effective at preventing infection in HIV-free individuals -- as long as those individuals take the drug every day as prescribed," CNN's "The Chart" reports (7/11).

13 Jul 2012

Discovery sheds light on why human body is unable to fight off HIV infection

University of Washington researchers have made a discovery that sheds light on why the human body is unable to adequately fight off HIV infection.

13 Jul 2012

High-risk HPV may increase chances of second malignancy in oral cancer

The proportion of oral squamous cell carcinoma patients infected with the human papillomavirus could be around a third, with high-risk versions of the virus accounting for almost three-quarters of those affected, indicate Taiwanese study results.

12 Jul 2012

SRI receives NIAID grant to develop HIV vaccine

The Scripps Research Institute has been awarded a grant expected to total more than $77 million from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID).

12 Jul 2012

Thrombopoietin mimetic offers aplastic anemia hope

Eltrombopag significantly improves blood counts in some patients with refractory severe aplastic anemia, suggests research published in The New England Journal of Medicine.

11 Jul 2012

OncoSec establishes UCSF as second enrolling site for OMS-I110 Phase II Merkel cell carcinoma trial

OncoSec Medical Inc., a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110).

11 Jul 2012

HIV infection risk reduced by same drugs that treat HIV

People at high risk of HIV infection can reduce their risk of acquiring the disease by taking antiretroviral drugs, according to Cochrane researchers. In an update of a systematic review first published in 2009, the researchers found that uninfected people in relationships with HIV-infected partners, men who have sex with men and those in other high risk groups are at a lower risk of becoming infected with the virus if they regularly take drugs that are normally prescribed to treat people with HIV.

11 Jul 2012

Fatal outcome from HFMD is rare, says LUHS pediatric infectious disease specialist

A mysterious disease that has killed nearly 60 children in Cambodia has been identified by the World Health Organization as enterovirus 71. This virus is one among a family of viruses that cause a variety of illnesses, including a common childhood illness called hand, foot and mouth disease, but Andrew Bonwit, MD, pediatric infectious disease specialist at Loyola University Health System, says a fatal outcome from such illness is rare.

11 Jul 2012

Former UNAIDS executive director discusses progress in AIDS fight ahead of AIDS 2012 conference

The 2012 International AIDS Conference, which will take place in Washington, D.C., from July 22-27, "will highlight a sense of optimism among top HIV researchers about stemming the spread of the virus around the globe," according to PRI's "The World."

11 Jul 2012

Liver failure, cancer and mortality in cirrhotic patients coinfected with HIV/AIDS and HCV predicted by liver stiffness

Researchers from Spain established that liver stiffness, measured by transient elastography (TE), is an independent predictor of liver failure, hepatocellular carcinoma (HCC), and mortality in cirrhotic patients coinfected with the human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS), and hepatitis C virus (HCV).

10 Jul 2012

Hepatitis C levels higher among males and African Americans

Epidemiologists have determined that levels of hepatitis C virus (HCV) found among injection drug users (IDUs) were higher in individuals who are male or African American even after differences in other factors were considered.

10 Jul 2012

Poor vaccine uptake blamed for polio rise in Pakistan, Afghanistan

The number of cases of poliomyelitis per year in Pakistan and Afghanistan has more than doubled since 2006 despite improvements in available vaccine efficacy, show study findings in The Lancet.

10 Jul 2012

Inovio commences SynCon vaccine phase I study in H1N1 influenza

Inovio Pharmaceuticals, Inc. announced today that the first patients have been treated in a clinical trial evaluating immune responses in elderly adults immunized with Inovio's H1N1 SynCon universal influenza vaccine.

10 Jul 2012

Associated Press examines 'sense of optimism' in HIV fight as AIDS 2012 conference approaches

Noting more than 20,000 international HIV researchers and activists will gather in Washington, D.C., for the AIDS 2012 conference later this month, the Associated Press writes that there is "a sense of optimism not seen in many years -- hope that it finally may be possible to dramatically stem the spread of the AIDS virus."

10 Jul 2012

Enterovirus blamed for some deaths of Cambodian children; Officials continue to investigate mysterious respiratory illness

"Lab tests have confirmed that a virulent strain of hand, foot and mouth disease known as [enterovirus-71 (EV-71)] is to blame for some of the 59 cases of mysterious illness among children in Cambodia reviewed since April, including 52 deaths, according to a joint statement from the World Health Organization and Cambodian Health Ministry," the Associated Press reports, noting that "the numbers were lowered from the initial report of 62 cases."

10 Jul 2012

Einstein researchers to study molecular mechanism behind Ebola virus infection

The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine of Yeshiva University a five-year, $4.8 million grant to study the molecular mechanism that allows the Ebola virus to cause infection and spread in animals.

10 Jul 2012

Alcoholic hepatitis linked to hepatitis C risk

Hepatitis C virus is more common in patients with alcoholic hepatitis than the general population, but infections may be going undetected, US data show.

9 Jul 2012

Maternal antiviral suppressive therapy may not be as effective as thought

Maternal antiviral suppressive therapy does not necessarily prevent the development of neonatal herpes simplex virus disease, warn researchers in The Journal of Pediatrics.

9 Jul 2012

Novel treatment for cancer based on protein from HIV-1 virus

Yissum, Research and Development Company of the Hebrew University of Jerusalem, introduces a novel method for treating cancer based on Vif, a protein isolated from the Human Immunodeficiency Virus (HIV-1). The method was invented by Professor Emeritus Moshe Kotler and Dr. Roni Nowarski from the Department of Immunology and Cancer Research at the Hebrew University.

9 Jul 2012

Virus News and Research

Latest Virus News and Research

Chica and Heinz Schaller Foundation supports work of five new C.H.S. research groups

Studies show success, highlight challenges of PrEP strategy

Discovery sheds light on why human body is unable to fight off HIV infection

High-risk HPV may increase chances of second malignancy in oral cancer

SRI receives NIAID grant to develop HIV vaccine

Thrombopoietin mimetic offers aplastic anemia hope

OncoSec establishes UCSF as second enrolling site for OMS-I110 Phase II Merkel cell carcinoma trial

HIV infection risk reduced by same drugs that treat HIV

Fatal outcome from HFMD is rare, says LUHS pediatric infectious disease specialist

Former UNAIDS executive director discusses progress in AIDS fight ahead of AIDS 2012 conference

Liver failure, cancer and mortality in cirrhotic patients coinfected with HIV/AIDS and HCV predicted by liver stiffness

Hepatitis C levels higher among males and African Americans

Poor vaccine uptake blamed for polio rise in Pakistan, Afghanistan

Inovio commences SynCon vaccine phase I study in H1N1 influenza

Associated Press examines 'sense of optimism' in HIV fight as AIDS 2012 conference approaches

Enterovirus blamed for some deaths of Cambodian children; Officials continue to investigate mysterious respiratory illness

Einstein researchers to study molecular mechanism behind Ebola virus infection

Alcoholic hepatitis linked to hepatitis C risk

Maternal antiviral suppressive therapy may not be as effective as thought

Novel treatment for cancer based on protein from HIV-1 virus

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in